For the quarter ending 2025-09-30, ULBI had -$1,681K decrease in cash & cash equivalents over the period. -$797K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | -1,247 | 2,749 |
| Depreciation | 1,008 | 1,958 |
| Amortization of intangible assets | 411 | 815 |
| Amortization of financing fees | 66 | 133 |
| Stock-based compensation | 236 | 462 |
| Deferred income taxes | 485 | -609 |
| Accounts receivable | -1,267 | 2,702 |
| Inventories | 2,229 | -1,102 |
| Prepaid expenses and other assets | 2,173 | -4,577 |
| Accounts payable and other liabilities | 3,344 | -400 |
| Net cash provided by operating activities | 198 | 9,303 |
| Proceeds from sale of equipment | 4 | - |
| Purchases of property, plant and equipment | 995 | 1,995 |
| Net cash used in investing activities | -991 | -1,995 |
| Payments on credit facilities-Revolving Credit Facility | -688 | -3,375 |
| Debt issuance costs | 0 | 24 |
| Proceeds from exercise of stock options | 37 | 61 |
| Net cash used in financing activities | -651 | -3,338 |
| Effect of exchange rate changes on cash | -237 | 117 |
| Increase (decrease) in cash | -1,681 | 4,087 |
| Cash and cash equivalents at beginning of period | 6,854 | - |
| Cash and cash equivalents at end of period | 9,260 | - |
ULTRALIFE CORP (ULBI)
ULTRALIFE CORP (ULBI)